Muenchener Rueck


Solid Q1 results, RoE of 10.4%

06/05/21 -"• Net premiums earned increased by 1% to €12.8bn in Q1 21 • COVID-19 claims were around €290m for Q1 21 compared to around €800m for Q1 20 • Pre-tax profit increased by 48% to €703m in Q1 21 • Net ..."

Pages
48
Language
English
Published on
06/05/21
You may also be interested by these reports :
07/06/21
Hannover Re (Buy, Germany) is such a smooth-running story that we have not felt any urge to tease about it over the last six years. Life has been a ...

04/06/21
Ageas (Add, Belgium) released last Tuesday its plan for the next three years, offering an interesting outlook and a very detailed strategy, enabling ...

04/06/21
We change opinion as we update our model and re-evaluate the importance of Ageas’ Asian business and, in particular, its Chinese exposure. While most ...

28/05/21
Aviva’s Q1 2021 trading update was positive. While operations remain flat with positive and negative performances offsetting each other in Savings & ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO